Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Inventory (2016 - 2025)

Historic Inventory for Fortress Biotech (FBIO) over the last 10 years, with Q3 2025 value amounting to $12.6 million.

  • Fortress Biotech's Inventory rose 668.48% to $12.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.6 million, marking a year-over-year increase of 668.48%. This contributed to the annual value of $14.9 million for FY2024, which is 4642.37% up from last year.
  • As of Q3 2025, Fortress Biotech's Inventory stood at $12.6 million, which was up 668.48% from $13.6 million recorded in Q2 2025.
  • In the past 5 years, Fortress Biotech's Inventory registered a high of $16.1 million during Q1 2022, and its lowest value of $2.3 million during Q1 2021.
  • Over the past 5 years, Fortress Biotech's median Inventory value was $12.5 million (recorded in 2025), while the average stood at $12.2 million.
  • As far as peak fluctuations go, Fortress Biotech's Inventory surged by 108403.64% in 2021, and later plummeted by 2791.86% in 2023.
  • Over the past 5 years, Fortress Biotech's Inventory (Quarter) stood at $9.9 million in 2021, then soared by 43.57% to $14.2 million in 2022, then dropped by 27.92% to $10.2 million in 2023, then soared by 46.42% to $14.9 million in 2024, then dropped by 15.85% to $12.6 million in 2025.
  • Its last three reported values are $12.6 million in Q3 2025, $13.6 million for Q2 2025, and $12.5 million during Q1 2025.